Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune system dysregulation.
• Suppressor cell dysfunction is a hallmark of active SLE, contributing to disease pathogenesis.

Purpose of the Study:

• To identify the specific cell types responsible for suppressor cell dysfunction in active SLE.
• To investigate the potential therapeutic role of soluble immune response suppressors (SIRS) in SLE.

Main Methods:

• Fractionation of blood mononuclear cells into T cells, B cells, and monocyte-depleted populations.
• Co-culture experiments with activated and non-activated cells from SLE patients and normal donors.
• Quantification of DNA-binding cells, anti-DNA antibodies, and immunoglobulin levels.
• Assessment of soluble immune response suppressors (SIRS) activity.

Main Results:

• Concanavalin A-activated T cells from active SLE patients were deficient in generating SIRS.
• Monocytes from active SLE patients responded to signals from activated T cells of normal or inactive SLE donors.
• SIRS from normal or inactive SLE donors suppressed B-cell functions in active SLE patients.
• Non-activated normal cells also demonstrated suppressive effects on B-cell functions.

Conclusions:

• T cell deficiency in generating SIRS is a key factor in suppressor cell dysfunction in active SLE.
• Monocytes in active SLE retain responsiveness to immune regulatory signals.
• SIRS shows potential as a therapeutic agent for modulating SLE in vivo.